Latin America Aortic Stent Graft Market Report and Forecast 2024-2032

The global aortic stent graft market was valued at USD 3.1 billion in 2023, with Latin America holding a significant market share. The market is driven by the growing demand for minimally invasive surgical techniques to treat vascular diseases. It is expected to grow at a CAGR of 5.8% during the forecast period of 2024-2032, with the values likely to attain USD 5.2 billion by 2032.

Latin America Aortic Stent Graft Market Outlook

• In January 2024, W. L. Gore & Associates, Inc., announced that the FDA has approved its lower profile GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis. The innovative stent graft offers more choices and flexibility to healthcare providers when treating patients with complicated blood vessel issues and is anticipated to elevate the Latin America aortic stent graft market value.
• Abdominal aortic aneurysm (AAA) is the most common form of aortic aneurysm, with older adults at a higher risk of developing the condition. The growing aging population in the Latin American region is likely to augment the market demand for effective treatment solutions including aortic stent grafts.
• The market share is influenced by the growing number of clinical trials and post-market surveillance studies to evaluate the effectiveness and safety profile of new aortic stent grafts.

Latin America Aortic Stent Graft Market Analysis

Aortic stent grafts are tube-like devices consisting of fabric-covered metal mesh. It is used in the treatment of aortic aneurysms and helps reinforce the wall of the aorta and prevent the aneurysm from rupturing. To repair an abdominal aortic aneurysm, a minimally invasive procedure called endovascular aneurysm repair (EVAR) is performed in which an aortic stent graft is required. There is a growing preference for minimally invasive surgeries as they are associated with shorter recovery times and lower risk of complications as compared to conventional open surgeries. This rising patient inclination towards endovascular aneurysm repair is expected to drive the Latin America aortic stent graft market growth in the coming years.

Abdominal aortic aneurysm (AAA) is the most common form of aortic aneurysm and poses a significant health challenge in Latin America. Older adults tend to be more susceptible to developing the condition, with the disease reported to be highly prevalent in patients over 60 years of age. As a minimally invasive treatment option, aortic stent grafts are suitable for elderly patients who may experience higher risks in open surgical techniques due to age-related health issues. Thus, the growing aging population in the region is likely to augment the market demand for effective treatment solutions including aortic stent grafts in healthcare settings.

One of the major Latin America aortic stent graft market trends is the rising technological advancements that are leading to the development of more effective and minimally invasive stent grafts. In January 2024, W. L. Gore & Associates, Inc., a global materials science company, announced that its lower profile GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) was approved by the United States Food and Drug Administration (FDA) for treating complex vascular disease. The innovative stent graft has 6 French (Fr) compatible configurations among balloon expandable stent-grafts, offering more choices and flexibility to healthcare providers when treating patients with complicated blood vessel issues. The introduction of such advanced medical devices in Latin American countries by the key market players is expected to elevate the market value in the forecast period.

The Latin America aortic stent graft market share is also influenced by the growing number of clinical trials to evaluate the effectiveness and safety profile of new aortic stent grafts. Further, the rise in post-market surveillance studies on stent grafts and endovascular aneurysm repair such as the Global Registry for Endovascular Aortic Treatment (the GREAT registry) is expected to enhance trust among patients and healthcare providers, leading to market expansion in the region.

Latin America Aortic Stent Graft Market Segmentation

The report offers a detailed analysis of the market based on the following segments:

Market Breakup by Product

• Abdominal Aortic Stent Grafts
• Thoracic Aortic Stent Grafts

Market Breakup by End User

• Hospitals
• Ambulatory Surgical Centres
• Others

Market Breakup by Country

• Brazil
• Argentina
• Mexico
• Others

Leading Players in the Latin America Aortic Stent Graft Market

The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Cook Medical, Inc.
• W.L. Gore & Associates
• MicroPort Scientific Corporation Inc.
• Medtronic Plc.
• Lombard Medical, Inc.
• Endologix, INC.
• Terumo Corporation Inc.
• Cardinal Health Inc.
• Becton, Dickinson and Company
• CryoLife Inc.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

FAQs

What is the Latin America aortic stent graft market forecast outlook for 2024-2032?
The Latin America aortic stent graft market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 5.8% during the forecast period of 2024-2032 and is likely to reach a market value of USD 5.2 billion by 2032.

What are the major factors aiding the Latin America aortic stent graft market demand?
The growing demand for minimally invasive surgical techniques to treat vascular diseases is fuelling the demand for the market.

What are the major Latin America aortic stent graft market trends?
One of the significant trends in the market is the rising technological advancements that are leading to the development of more effective and minimally invasive stent grafts. In January 2024, W. L. Gore & Associates, Inc., announced the FDA approval of it lower profile GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis, aimed at treating complex vascular diseases.

What is the market segmentation based on the product?
Based on the product, the market is segmented into abdominal aortic stent grafts and thoracic aortic stent grafts.

What are the major end users of the market?
End users of the market are hospitals and ambulatory surgical centers, among others.

What is the market segmentation by countries?
The market segmentation by countries includes Brazil, Argentina, and Mexico, among others.

Who are the key players involved in the Latin America aortic stent graft market?
The key players in the market are Cook Medical, Inc., W.L. Gore & Associates, MicroPort Scientific Corporation Inc., Medtronic Plc., Lombard Medical, Inc., Endologix, INC., Terumo Corporation Inc., Cardinal Health Inc., Becton, Dickinson and Company, and CryoLife Inc.


This product will be delivered within 5-7 business days.